Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

SVA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.13%

Insider Buying (Last 12 Months): C$97,671.00

Insider Selling (Last 12 Months): C$223,200.00

Sernova Insider Trading History Chart

Sernova Share Price & Price History

C^$0.22

+0.30 (1.20%)

As of 12/24/2024 02:21 PM ET

Days: 30 | 90 | 365

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

Sernova Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/17/2024	Steven Sangha	Director	Buy	20,000	C$0.25	C$4,900.00
9/13/2024	Steven Sangha	Director	Buy	22,600	C$0.26	C$5,876.00
8/27/2024	Steven Sangha	Director	Sell	930,000	C$0.24	C$223,200.00
8/15/2024	Steven Sangha	Director	Buy	100,000	C$0.23	C$23,000.00
8/6/2024	Steven Sangha	Director	Buy	100,000	C$0.24	C$24,000.00
7/30/2024	Steven Sangha	Director	Buy	35,000	C$0.28	C$9,625.00
7/22/2024	Steven Sangha	Director	Buy	11,000	C$0.28	C$3,080.00
7/19/2024	Steven Sangha	Director	Buy	51,000	C$0.29	C$14,790.00
7/15/2024	Steven Sangha	Director	Buy	40,000	C$0.31	C$12,400.00
6/17/2022	Frank Holler	Director	Buy	50,000	C$1.29	C$64,500.00	583,333

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

SEC Filings (Institutional Ownership Changes) for Sernova (TSE:SVA)

0.05% of Sernova stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

Today's Range

Now: C$0.22

C$0.22

50 Day Range

MA: C$0.24

C$0.22

C$0.27

52 Week Range

Now: C$0.22

C$0.20

C$0.73

Volume

23,500 shs

Average Volume

159,463 shs

Market Capitalization

C$71.57 million

P/E Ratio

N/A

Dividend Yield

7.86%

Beta

1.35

Who are the company insiders with the largest holdings of Sernova?: Sernova's top insider investors include:
Steven Sangha (Director)
Learn More about top insider investors at Sernova.